Swati Bhayana Leads Breakthrough Pediatric Sickle Cell Cure in India
Swati Bhayana, Consultant at Fortis Healthcare, shared a post by Biomall.in on LinkedIn:
”Gratitude to the amazing team of doctors, nurses, hospital management who supported endlessly for the dream
– We are the force.”
Quoting Biomall.in’s post:
”Hope for Sickle Cell: A Breakthrough in India’s Pediatric Care
India marks a major milestone in the fight against Sickle Cell Disease (SCD) with a decade-long clinical study demonstrating the transformative potential of pediatric stem-cell transplantation.
Led by Dr. SWATI BHAYANA, a leading pediatric hematologist at Fortis Healthcare Gurugram, the team has reported remarkable outcomes:~87% overall survival rate among children undergoing stem-cell transplant 96% survival when the donor is a matched sibling, Significant reduction in long-term complications, and improved quality of life
This achievement brings India closer to offering globally benchmarked curative therapy, especially critical for high-burden tribal and underserved regions. It underscores the power of clinical innovation, strong donor-matching programs, and advanced transplant care in reshaping SCD management.
Read the full article here.”
Title: Indian Healthcare Achieves Global Standards in Pediatric SCD Cure
Stay informed with Hemostasis Today.
-
Mar 3, 2026, 14:21Danny Hsu: The 2nd THANZ Webinar Series To Bring Timely Updates in Thrombosis and Hemostasis
-
Mar 3, 2026, 14:10Kalyan Roy: Understanding Erythroblastosis Fetalis
-
Mar 3, 2026, 14:04Najah Sampson: Understanding Key Risk Factors and Symptoms of VTE
-
Mar 3, 2026, 09:10From Fear to Freedom: Hemophilia A, Emicizumab Prophylaxis, and the Rewriting of a Childhood
-
Mar 3, 2026, 09:01Amy Owen-Wyard: A Life Should Not Have a Price Tag Attached to Its Rarity
-
Mar 3, 2026, 08:54Kanishk Kumar: Novel Complement Inhibitors and Next-Generation Therapies as Driving Momentum for aHUS
-
Mar 3, 2026, 08:48Megan Adediran: Redefining Rare Diseases in Nigeria’s Healthcare System
-
Mar 3, 2026, 08:18Peter Zdziarski: A Brighter Future for Glanzmann Thrombasthenia Through Gene Therapy
-
Mar 2, 2026, 17:22Hematologists and Oncologists Recognize Their Role in Specialized VA Care Despite Ongoing Knowledge Gaps – JTH